Presenter: David O. Apiyo, Ph.D., Field Applications During therapeutic antibody development, panels of monoclonal antibodies are routinely screened for their epitope binding regions. Antibodies that bind to the same or overlapping regions of an antigen are categorized into epitope groups or "bins." Depending on the design of the assay, results of epitope binning assays can be difficult to interpret. In this webinar, we will discuss techniques for label-free epitope binning studies and methods currently in use. The strengths of different assay formats will be considered. Approaches to antibody pair selection will also be discussed.